Baystreet Staff - Thursday, July 17, 2008 QLT Inc. 09:49 AM EST - QLT Inc. : announced that Novartis reported global sales of QLT's Visudyne product of US$40.7 million for the second quarter, a decline of 31.5% from the same period last year. QLT Inc. shares T.QLT are trading off 3 cents at $3.77.
